New Momentum in Pharma Automation: ArisGlobal's 2024 Industry Survey Report Highlights Surge in AI-Powered Safety & Regulatory Processes

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

ArisGlobal-Survey2024

More Like This

PR Newswire associated0

Survey: Unsustainable Regulatory Workloads Leave No Choice About AI Adoption

PR Newswire associated0

Pioneering the Next Frontier: ArisGlobal Unveils Cutting-Edge Safety & Regulatory Product Offerings Powered by Generative AI

PR Newswire associated0

Newest Version of LifeSphere® Regulatory Platform Allows Organizations to Leverage Latest GenAI Technology

PR Newswire associated0

Medac GmbH Advances Pharmacovigilance Technology for Safety Monitoring of its Drugs with ArisGlobal Solutions

PR Newswire associated0

Top 5 Global Biotech Company Goes Live with LifeSphere® MultiVigilance and Reporting & Analytics Solution

PR Newswire associated0

Breakthrough 2024 Speaker Lineup Announced - Industry Experts to Discuss the Evolution of Life Sciences Through Technology, Automation, and Artificial Intelligence

PR Newswire associated0

Significant Case Intake Efficiencies Found in Newly Launched Life Sciences Generative AI Solution

PR Newswire associated0

New Study Confirms Power of Real-World Data in Proactive Signal Detection, Improving Patient Safety